Clinical Research Directory
Browse clinical research sites, groups, and studies.
Association of Anti-factor Xa Activity With Venous Thromboembolism in Critically Ill Patients
Sponsor: Medical University of Vienna
Summary
The goal of this observational study is to analyse the association between anti-factor Xa activity (antiXa) and the occurence of venous thromboembolism (VTE; either deep vein thrombosis and/or pulmonary embolism) in critically ill patients who are admitted to an intensive care unit. The main questions it aims to answer are: * What is the association between antiXa and VTE? * What is the association between antiXa and symptomatic, respectively incidental, VTE? * How is pharmacological anticoagulation with enoxaparin related to measured antiXa? * What is the association between antiXa and bleeding complications. * What is the incidence of venous thromboembolism in patients treated at an intensive care unit? * How is the occurence of VTE related to patient-centred outcomes such as mortality, quality of life, length of stay and days outside of the intensive care unit/hospital.
Official title: Association of Anti-factor Xa Activity With Venous Thromboembolism in Critically Ill Patients: a Prospective Multicentre Cohort Study
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
1300
Start Date
2024-05-04
Completion Date
2027-08
Last Updated
2025-09-29
Healthy Volunteers
No
Conditions
Interventions
Anti-factor Xa activity calibrated for enoxaparin
Anti-factor Xa activity calibrated for enoxaparin
Locations (2)
Department of Internal Medicine, Medical University of Graz
Graz, Styria, Austria
Department of Anaesthesia, Intensive Care Medicine and Pain Medicine, Medical University of Vienna
Vienna, Austria